A Study of Real Life Treatment for Multiple Myeloma (MM)

Active, not recruitingOBSERVATIONAL
Enrollment

357

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

June 20, 2026

Study Completion Date

June 20, 2026

Conditions
Multiple Myeloma
Trial Locations (24)

125167

National Research Center of Hematology of the Ministry of Health, Moscow

125284

Herzen Moscow Scientific Research Oncological Institute, Moscow

129110

Moscow Regional Research Clinical Institute n.a. M.F. Vladimirsky, Moscow

160002

Vologda Regional Clinical Hospital, Vologda

185019

Republican hospital named after V.A.Baranov, Petrozavodsk

197110

City Clinical Hospital No. 31, Saint Petersburg

214025

Smolensk Clinical Hospital of Russian Railways-Medicine, Smolensk

238022

BaltikMed Clinic, Kaliningrad

248007

Kaluga Regional Clinical Hospital, Kaluga

398007

"GUZ Lipetsk City Hospital No. 3 Free Falcon ", Lipetsk

400001

Clinic Akademicheskaya LLC, Volgograd

410028

Razumovskiy Saratov State Medical University, University Clinical, Saratov

420064

Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan'

432017

Ulyanovsk Regional Clinical Hospital, Ulyanovsk

450005

Republican Clinical Hospital named after G.G. Kuvatov, Ufa

460018

Orenburgskaya Regional Clinical Hospital n.a. V.I. Voinova, Orenburg

603003

City Clinical Hospital No. 12, Nizhny Novgorod

610027

Kirov Research Institute of Hematology and Blood Transfusion, Kirov

628012

District Clinical Hospital, Khanty-Mansiysk

628408

Surgut Regional Clinical Hospital, Surgut

630051

Novosibirsk State Medical University, Department of Therapy, Hematology and Transfusiology based on City Clinical Hospital No. 2, Novosibirsk

634063

Tomsk Regional Clinical Hospital, Tomsk

656024

Altai Regional Clinical Hospital, Barnaul

680009

City Clinical Hospital No. 1 named after prof. S.I.Sergeev, Khabarovsk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY